460 related articles for article (PubMed ID: 2784355)
1. The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate.
Lahat N; Alexander B; Levin DR; Moskovitz B
Cancer Immunol Immunother; 1989; 28(3):208-12. PubMed ID: 2784355
[TBL] [Abstract][Full Text] [Related]
2. Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon.
Flodgren P; Sjögren HO
Cancer Immunol Immunother; 1985; 19(1):28-34. PubMed ID: 3844972
[TBL] [Abstract][Full Text] [Related]
3. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
Front Immunol; 2018; 9():3169. PubMed ID: 30761160
[No Abstract] [Full Text] [Related]
4. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
5. Immunological effects of flavone acetic acid.
Triozzi PL; Rinehart JJ; Malspeis L; Young DC; Grever MR
Cancer Res; 1990 Oct; 50(20):6483-5. PubMed ID: 2208107
[TBL] [Abstract][Full Text] [Related]
6. Restoration of anti-interleukin-1 depressed natural killer activity by human recombinant interferon alpha or gamma, human recombinant interleukin-2 and indomethacin.
Conti P; Reale M; Angeletti PU; Dinarello CA
Int J Immunopharmacol; 1988; 10(8):907-11. PubMed ID: 3145923
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
Shi B; Qi J
J Cell Physiol; 2021 Apr; 236(4):2620-2630. PubMed ID: 32853461
[TBL] [Abstract][Full Text] [Related]
8. The relationship of natural killer cells to metastasis of a transplantable prostate adenocarcinoma.
Wade AC; Schmidt MA; Pollard M
Prostate; 1985; 7(1):53-61. PubMed ID: 2417216
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
Damle NK; Doyle LV; Bradley EC
J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
[TBL] [Abstract][Full Text] [Related]
10. Effect of pemetrexed on innate immune killer cells and adaptive immune T cells in subjects with adenocarcinoma of the pancreas.
Davis M; Conlon K; Bohac GC; Barcenas J; Leslie W; Watkins L; Lamzabi I; Deng Y; Li Y; Plate JM
J Immunother; 2012 Oct; 35(8):629-40. PubMed ID: 22996369
[TBL] [Abstract][Full Text] [Related]
11. The relationship of clinical-pathologic status and adjuvant treatment with natural killer cell activity in stage I and II endometrial carcinoma.
Garzetti GG; Ciavattini A; Muzzioli M; Goteri G; Fabris N; Valensise H; Romanini C
Acta Obstet Gynecol Scand; 1994 Sep; 73(8):652-7. PubMed ID: 7941992
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immunomodulative effects of histamine-2 receptor antagonists in gastric cancer patients: focus on the lymphoblastogenesis and cytotoxicity of peripheral blood mononuclear cells.
Hahm KB; Lee SI; Chung JP; Kim WH; Kim JH; Park IS
Int J Immunopharmacol; 1994 Dec; 16(12):985-93. PubMed ID: 7705971
[TBL] [Abstract][Full Text] [Related]
13. Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer cells.
Itoh K; Platsoucas CD; Tilden AB; Pollock RE; Balch CM
Cell Immunol; 1987 Sep; 108(2):283-96. PubMed ID: 3113741
[TBL] [Abstract][Full Text] [Related]
14. Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose.
Palmer PA; Scharenberg JG; von Blomberg BM; Stam AG; Meijer CJ; Roest GJ; Franks CR; Scheper RJ
Cancer Immunol Immunother; 1994 Jul; 39(1):34-40. PubMed ID: 8044824
[TBL] [Abstract][Full Text] [Related]
15. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
Liljefors M; Nilsson B; Hjelm Skog AL; Ragnhammar P; Mellstedt H; Frödin JE
Int J Cancer; 2003 Jul; 105(5):717-23. PubMed ID: 12740924
[TBL] [Abstract][Full Text] [Related]
16. Leukocytic subset distributions of spleen cells obtained from rats bearing variants of the Dunning prostatic adenocarcinoma.
Shaw MW; Bhatti R; McKiel CF; Guinan PD; Rubenstein M
J Urol; 1986 Jan; 135(1):159-62. PubMed ID: 2934556
[TBL] [Abstract][Full Text] [Related]
17. [Effect of surgical trauma on NK cell activity in esophageal carcinoma after transmediastinal dissection vs. transthoracic en bloc resection].
Bruns C; Schäfer H; Wolfgarten B; Pichlmaier H
Langenbecks Arch Chir; 1996; 381(3):175-81. PubMed ID: 8767378
[TBL] [Abstract][Full Text] [Related]
18. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.
Suzuki K; Nakazato H; Matsui H; Hasumi M; Shibata Y; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
J Leukoc Biol; 2001 Apr; 69(4):531-7. PubMed ID: 11310838
[TBL] [Abstract][Full Text] [Related]
19. Effect of indomethacin on tumor-infiltrating lymphocytes of a spontaneously developed murine mammary adenocarcinoma.
Chao TY; Chu TM
Cancer Immunol Immunother; 1989; 30(3):158-64. PubMed ID: 2598184
[TBL] [Abstract][Full Text] [Related]
20. Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.
Stangl S; Gross C; Pockley AG; Asea AA; Multhoff G
Cell Stress Chaperones; 2008; 13(2):221-30. PubMed ID: 18759005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
